Claris Lifesciences makes inroads into Germany

AHMEDABAD: Claris Lifesciences, which recently attracted investment from leading international pharma group Carlyle, has formally made inroads into the German market,

The firm is also in parleys with a few top pharma companies in the US and Europe for out-licensing and in-licensing products. “We are in talks with a few pharma companies for licensing agreement for five of our products,” Sushil Handa, chairman, Claris Lifesciences told ET.